Sangamo Therapeutics, Inc.
SGMO
$0.15
-$0.02-12.73%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.00M | -37.42M | -34.93M | -19.99M | -30.60M |
| Total Depreciation and Amortization | 877.00K | 1.88M | 1.90M | 1.90M | 1.92M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 992.00K | 15.36M | 2.13M | 2.26M | 2.60M |
| Change in Net Operating Assets | 9.84M | -4.23M | 2.41M | -2.33M | -77.00K |
| Cash from Operations | -19.28M | -24.40M | -28.50M | -18.16M | -26.15M |
| Capital Expenditure | -13.00K | -14.00K | -64.00K | -24.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.00K | -14.00K | -64.00K | -24.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.08M | 15.15M | 19.47M | 29.03M | 10.36M |
| Repurchase of Common Stock | -379.00K | -349.00K | -267.00K | -420.00K | -2.23M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.70M | 14.80M | 19.20M | 28.61M | 8.13M |
| Foreign Exchange rate Adjustments | -766.00K | 40.00K | 42.00K | 2.73M | 1.28M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.64M | -9.58M | -9.32M | 13.16M | -16.74M |